Spread the love“`html It’s a curious paradox, isn’t it? We’re constantly told that technology is advancing, that innovation ...

For more than a decade, CAR-T cell therapy has been one of the biggest breakthroughs in cancer medicine. By reprogramming a ...

Response rates to second-line STS therapies, including pazopanib, are typically <10% with median PFS <5 months, underscoring demand for predictive biomarkers. Transcriptomic profiling of 11 paired pre ...

MiNK Therapeutics (NASDAQ:INKT) said it initiated dosing in a randomized Phase II trial of its allogeneic invariant natural killer T-cell therapy, agenT-797, for patients with acute lung injury and ...

Year-to-Date Operating Expense Reduction: Total operating expenses for the six months ended June 30, 2026 decreased by $14.3 million compared to the same period in 2025, reflecting a $7.5 million, 13% ...

The nucleus of the cells of interest has been labeled scarlet. Credit: University of Manchester Researchers found that a little-known group of immune cells is crucial for keeping cancer-fighting T ...

For patients with blood cancers like leukemia and lymphoma, the immunotherapy known as CAR-T cell therapy can be lifesaving. Doctors remove a patient's immune cells, called T cells, engineer them in ...

If you use a disinfectant wipe or cleaner to tackle everyday spills, experts say you may be cleaning the wrong way — and ...

Toxoplasma gondii, or Toxoplasma, is a parasite that infects hundreds of millions of people around the world. Although cases are often mild, it can cause severe symptoms in people with weakened immune ...